文献速递胃肠外科

内镜治疗在T1b期胃癌中的疗效及预后预测模型的构建:回顾性队列与多中心验证研究

Efficacy of endoscopic therapy in patients with T1b gastric cancer and construction of a prognostic prediction model: a retrospective cohort study and multicenter validation study.
PubMed 文献 · Surg Endosc · 2025-11-19

本研究基于SEER数据库2010-2020年2020例T1b期胃癌患者及中国多中心116例患者数据,比较内镜治疗、胃切除术与放化疗的长期生存。分析显示胃切除术与内镜治疗的长期生存无统计学显著差异,放化疗疗效明显劣于内镜治疗;基于Lasso回归构建的预后模型对总生存具有满意预测准确性。

要点

  • T1b期胃癌内镜治疗与胃切除术的长期生存无统计学显著差异。
  • 放化疗疗效明显劣于内镜治疗。
  • 基于种族、性别、年龄、组织学分级、肿瘤大小和治疗策略的预后模型预测OS表现良好。

核心结论

  • T1b期胃癌患者胃切除术的长期生存优势与内镜治疗相当。
  • 本研究构建的预后模型在预测T1b期胃癌患者总生存方面表现稳健。

研究设计与样本

  • 回顾性队列研究,提取SEER数据库2010-2020年T1b期胃癌患者数据,共纳入2020例。
  • 另收集中国多中心数据库相关患者临床特征和生存指标,共116例用于验证。
  • 采用未调整、稳定逆概率加权治疗(IPTW)和倾向性评分匹配(PSM)多种方法评估总生存(OS)和癌症特异性生存(CSS)。
  • 通过最小绝对收缩和选择算子(Lasso)回归进行变量选择,构建并验证预后模型。

主要发现

  • 在SEER数据库多种比较框架中,胃切除术与内镜治疗的长期生存无统计学显著差异。
  • 放化疗疗效明显劣于内镜治疗。
  • 中国多中心数据库116例患者分析 corroborated 上述发现。
  • Lasso回归最终纳入预后模型的变量包括种族、性别、年龄、组织学分级、肿瘤尺寸和治疗策略。
  • 该模型对T1b期胃癌患者OS表现出满意的预测准确性。

临床怎么用

  • 对于T1b期胃癌,内镜治疗可作为与胃切除术长期生存相当的选项,需结合患者具体情况个体化决策。
  • 放化疗不作为优于内镜治疗的替代方案。
  • 构建的预后模型可用于预测T1b期胃癌患者总生存,辅助临床决策。

局限性

  • 本研究为回顾性队列研究,存在回顾性偏倚可能。
  • 原文未报告具体局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of this study was to elucidate the disparities in long-term survival outcomes between endoscopic therapy and gastrectomy in T1b gastric cancer (GC) patients METHODS: Data pertaining to T1b GC patients from 2010-2020 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Additionally, clinical characteristics and survival metrics for pertinent patients were collated from the Chinese multicenter database. Overall survival (OS) and cancer-specific survival (CSS) were evaluated using various methodologies [unadjusted, stable inverse probability-weighted treatment (IPTW), and propensity score matching (PSM)] among the endoscopy, gastrectomy, and chemoradiotherapy cohorts. Variable selection was conducted through the Least Absolute Shrinkage and Selection Operator (Lasso) regression, culminating in the development and validation of a prognostic model across distinct cohorts RESULTS: In all, 2020 GC patients were identified through the SEER database. Multiple comparative frameworks were employed to scrutinize the differences in outcomes among gastrectomy, endoscopy, and chemoradiotherapy modalities. The analyses revealed no statistically significant disparity in long-term survival between gastrectomy and endoscopy while demonstrating that the efficacy of chemoradiotherapy was markedly inferior to that of endoscopy. Further validation was achieved by analyzing data from 116 patients from the Chinese multicenter database, corroborating the aforementioned findings. Subsequently, Lasso regression facilitated the variable selection for the prognostic model, which ultimately included race, gender, age, histologic grade, tumor dimensions, and treatment strategy. The model demonstrated satisfactory predictive accuracy for OS among T1b GC patients CONCLUSION: The long-term survival advantage conferred by gastrectomy in patients with T1b GC was found to be commensurate with that achieved through endoscopic therapy. The prognostic model formulated in this study exhibited robust performance in forecasting the OS of T1b GC patients.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Zhao F, Lan Y, Wu X, et al. Efficacy of endoscopic therapy in patients with T1b gastric cancer and construction of a prognostic prediction model: a retrospective cohort study and multicenter validation study. Surg Endosc. 2025. PMID: 41261250. doi:10.1007/s00464-025-12384-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。